Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Piotr Damiański, Grzegorz Kardas, Michał Panek, Piotr Kuna & Maciej Kupczyk. (2022) Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions. Expert Opinion on Drug Safety 21:4, pages 499-515.
Read now
Read now
Anne Orholm Nielsen, Ole Hilberg, Jens Ulrik Stæhr Jensen, Steffen Helmer Kristensen, Jannie Christina Frølund, Pernille Kølholt Langkilde & Anders Løkke. (2021) Withdrawal of Inhaled Corticosteroids in Patients with COPD – A Prospective Observational Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 807-815.
Read now
Read now
Ji-Ho Lee, You Hyun Park, Dae Ryong Kang, Seok Jeong Lee, Myoung Kyu Lee, Sang-Ha Kim, Suk Joong Yong & Won-Yeon Lee. (2020) Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3397-3406.
Read now
Read now
Anna Jetske Baron, Bertine M J Flokstra-de Blok, Ellen van Heijst, Roland A Riemersma, Agnes M M Sonnenschein-van der Voort, Esther I Metting & Janwillem W H Kocks. (2020) Prevalence of Asthma Characteristics in COPD Patients in a Dutch Well-Established Asthma/COPD Service for Primary Care. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1601-1611.
Read now
Read now
Sergey Avdeev, Zaurbek Aisanov, Vladimir Arkhipov, Andrey Belevskiy, Igor Leshchenko, Svetlana Ovcharenko, Evgeny Shmelev & Marc Miravitlles. (2019) Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1267-1280.
Read now
Read now
Meng-Jer Hsieh, Shu-Yi Huang, Tsung-Ming Yang, Chi-Wei Tao, Shih-Lung Cheng, Chao-Hsien Lee, Ping-Hung Kuo, Yao-Kuang Wu, Ning-Hung Chen, Wu-Huei Hsu, Jeng-Yuan Hsu, Ming-Shian Lin, Chin-Chou Wang, Yu-Feng Wei & Ying-Huang Tsai. (2018) The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2949-2959.
Read now
Read now
José Luis Izquierdo & Borja G Cosio. (2018) The dose of inhaled corticosteroids in patients with COPD: when less is better. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3539-3547.
Read now
Read now
John R Hurst, Maria Dilleen, Kevin Morris, Siân Hills, Birol Emir & Rupert Jones. (2018) Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 781-792.
Read now
Read now
Peter M. A. Calverley, Helgo Magnussen, Marc Miravitlles & Jadwiga A. Wedzicha. (2017) Triple Therapy in COPD: What We Know and What We Don't. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:6, pages 648-662.
Read now
Read now
Filipe Froes, Nicolas Roche & Francesco Blasi. (2017) Pneumococcal vaccination and chronic respiratory diseases. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3457-3468.
Read now
Read now
Silvia Cascini, Ursula Kirchmayer, Valeria Belleudi, Lisa Bauleo, Riccardo Pistelli, Mirko Di Martino, Giulio Formoso, Marina Davoli & Nera Agabiti. (2017) Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and Risk of Pneumonia: A Nested Case-Control Population-based Study in Lazio (Italy)—The OUTPUL Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:3, pages 311-317.
Read now
Read now
Donald Banerji, Donald A. Mahler & Nicola A. Hanania. (2016) Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD. Expert Review of Respiratory Medicine 10:7, pages 767-780.
Read now
Read now
Jadwiga A Wedzicha, Peter MA Calverley & Klaus F Rabe. (2016) Roflumilast: a review of its use in the treatment of COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 81-90.
Read now
Read now
Junghyun Kim, Jung-Kyu Lee, Eun Young Heo, Hee Soon Chung & Deog Kyeom Kim. (2016) The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2159-2166.
Read now
Read now
Girolamo Pelaia, Carmelo Caio Muzzio, Alessandro Vatrella, Rosario Maselli, Maria Sandra Magnoni & Andrea Rizzi. (2015) Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment. Expert Opinion on Pharmacotherapy 16:13, pages 2009-2021.
Read now
Read now
David M Kern, Jill Davis, Setareh A Williams, Ozgur Tunceli, Bingcao Wu, Sally Hollis, Charlie Strange & Frank Trudo. (2015) Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1417-1425.
Read now
Read now
Edvardas Bagdonas, Jovile Raudoniute, Ieva Bruzauskaite & Ruta Aldonyte. (2015) Novel aspects of pathogenesis and regeneration mechanisms in COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 995-1013.
Read now
Read now
Shih-Lung Cheng, Kang-Cheng Su, Hao-Chien Wang, Diahn-Warng Perng & Pan-Chyr Yang. (2014) Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia. Drug Design, Development and Therapy 8, pages 601-607.
Read now
Read now
Junji Lin, Yunfeng Li, Haijun Tian, Michael J Goodman, Susan Gabriel, Tara Nazareth, Stuart J Turner, Stephen Arcona & Kristijan H Kahler. (2014) Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia. ClinicoEconomics and Outcomes Research 6, pages 349-356.
Read now
Read now
Gaetano Caramori, Kian Fan Chung & Ian M Adcock. (2014) Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 249-256.
Read now
Read now
Eric D Bateman, Donald A Mahler, Claus F Vogelmeier, Jadwiga A Wedzicha, Francesco Patalano & Donald Banerji. (2014) Recent advances in COPD disease management with fixed-dose long-acting combination therapies. Expert Review of Respiratory Medicine 8:3, pages 357-379.
Read now
Read now
Mario Cazzola, Paola Rogliani, Lucia Novelli & Maria Gabriella Matera. (2013) Inhaled corticosteroids for chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:18, pages 2489-2499.
Read now
Read now
Ruben D Restrepo, Andrew Tate & Joshua Coquat. (2013) Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:14, pages 1993-2002.
Read now
Read now
Articles from other publishers (52)
Sanjay SethiSwetha R PalliLindsay G S BengtsonErin K BuysmanBrendan ClarkAndrew SargentAsif ShaikhGary T Ferguson. (2023) Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. Journal of Managed Care & Specialty Pharmacy 29:7, pages 791-806.
Crossref
Crossref
Esther Pacheco, Augustine J. Sohn, Christina Wells, Lisa K. Sharp, Samantha Madrid, Todd A. Lee, Yi-Fan Chen, Barbara P. Yawn, Diana Garcia, Kyungran Shim, Nancy Quesada & Min J. Joo. (2022) Design of the Reducing Diagnostic Error to Improve Patient Safety (REDEfINE) in COPD and asthma study: A cluster randomized comparative effectiveness trial. Contemporary Clinical Trials 123, pages 106971.
Crossref
Crossref
Xiaofeng Pu, Liang Liu, Bimin Feng, Zhengji Zhang & Guojun Wang. (2021) Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis. Respiratory Research 22:1.
Crossref
Crossref
V. V. Salukhov, E. V. Kryukov, M. A. Kharitonov, V. P. Sereda & A. A. Minakov. (2021) Triple therapy in a single inhaler for chronic obstructive pulmonary disease: clinical studies and case report (real practice). Meditsinskiy sovet = Medical Council:16, pages 174-184.
Crossref
Crossref
Marc Miravitlles, Ariadna Auladell-Rispau, Mònica Monteagudo, Juan Carlos Vázquez-Niebla, Jibril Mohammed, Alexa Nuñez & Gerard Urrútia. (2021) Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. European Respiratory Review 30:160, pages 210075.
Crossref
Crossref
Rui Ye, Cuihong Wang, Pengbo Sun, Shuang Bai & Li Zhao. (2021) AGR3 Regulates Airway Epithelial Junctions in Patients with Frequent Exacerbations of COPD. Frontiers in Pharmacology 12.
Crossref
Crossref
Mahnaz Mozdourian & Rozita Khodashahi. (2021) Association between the Use of Inhaled Corticosteroids and Pulmonary Nontuberculous Mycobacterial Infection: A Systematic Review. Current Respiratory Medicine Reviews 16:2, pages 113-122.
Crossref
Crossref
Swetha R. PalliMonica FrazerMary DuCharmeAmi R. BuikemaAmy J. AndersonJessica Franchino-Elder. (2020) Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy. Journal of Managed Care & Specialty Pharmacy 26:10, pages 1363-1374.
Crossref
Crossref
Toral J. Parikh, Krysttel C. Stryczek, Chris Gillespie, George G. Sayre, Laura Feemster, Edmunds Udris, Barbara Majerczyk, Seppo T. Rinne, Renda Soylemez Wiener, David H. Au & Christian D. Helfrich. (2020) Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids. PLOS ONE 15:9, pages e0238511.
Crossref
Crossref
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, I. V. Leshchenko, S. I. Ovcharenko, A. V. Emel'yanov, I. V. Demko, G. L. Ignatova, I. N. Trofimenko & E. I. Shmelev. (2020) Inhalation glucocorticosteroids in the treatment of chronic obstructive pulmonary disease. Russian Pulmonology 30:3, pages 330-343.
Crossref
Crossref
Эльвира Зуферовна Кудрявцева, Наталья Николаевна Макарьянц & Лидия Юрьевна Никитина. (2020) ОСОБЕННОСТИ ОБОСТРЕНИЙ У ПАЦИЕНТОВ С РАЗЛИЧНЫМИ ФЕНОТИПАМИ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ, "Вестник Центрального научно-исследовательского института туберкулеза". Вестник ЦНИИТ:2, pages 36-48.
Crossref
Crossref
Pietro Pirina, Elisabetta Zinellu, Marco Martinetti, Claudia Spada, Barbara Piras, Claudia Collu & Alessandro Giuseppe Fois. (2020) Treatment of COPD and COPD–heart failure comorbidity in primary care in different stages of the disease. Primary Health Care Research & Development 21.
Crossref
Crossref
Holger Gothe, Sasa Rajsic, Djurdja Vukicevic, Tonio Schoenfelder, Beate Jahn, Sabine Geiger-Gritsch, Diana Brixner, Niki Popper, Gottfried Endel & Uwe Siebert. (2019) Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review. BMC Health Services Research 19:1.
Crossref
Crossref
Swetha R Palli, Ami R Buikema, Mary DuCharme, Monica Frazer, Shuchita Kaila & Timothy Juday. (2019) Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease. Journal of Comparative Effectiveness Research 8:15, pages 1299-1316.
Crossref
Crossref
Cheng-Yi Wang, You Shuei Lin, Ya-Hui Wang, Chih-Cheng Lai, Hao-Chien Wang, Likwang Chen & Chong-Jen Yu. (2019) Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists. Aging 11:17, pages 6863-6871.
Crossref
Crossref
Samuel J.W. White, William A. Ranson, Brian Cho, Zoe B. Cheung, Ivan Ye, Oscar Carrillo, Jun S. Kim & Samuel K. Cho. (2019) The Effects of Preoperative Steroid Therapy on Perioperative Morbidity and Mortality After Adult Spinal Deformity Surgery. Spine Deformity 7:5, pages 779-787.
Crossref
Crossref
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, I. V. Leshchenko, S. I. Ovcharenko, E. I. Shmelev & M. Miravitls. (2019) Withdrawal of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Russian Pulmonology 29:3, pages 334-345.
Crossref
Crossref
Samuel J.W. White, Oscar Carrillo, Zoe B. Cheung, William A. Ranson & Samuel Kang-Wook Cho. (2019) The Effects of Preoperative Steroid Therapy on Perioperative Complications After Elective Anterior Lumbar Fusion. World Neurosurgery 126, pages e314-e322.
Crossref
Crossref
Donald P. Tashkin, Marc Miravitlles, Bartolomé R. Celli, Norbert Metzdorf, Achim Mueller, David M. G. Halpin & Antonio Anzueto. (2018) Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial. Respiratory Research 19:1.
Crossref
Crossref
Vincent X. Liu, Kevin L. Winthrop, Yun Lu, Husham Sharifi, Hekmat U. Nasiri & Stephen J. Ruoss. (2018) Association between Inhaled Corticosteroid Use and Pulmonary Nontuberculous Mycobacterial Infection. Annals of the American Thoracic Society 15:10, pages 1169-1176.
Crossref
Crossref
Songsong Yu, Qiuhong Fang & Yinjuan Li. (2018) Independent factors associated with pneumonia among hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease. Medicine 97:42, pages e12844.
Crossref
Crossref
Hideki Yasui, Naoki Inui, Tomoyuki Fujisawa, Masato Karayama, Noriyuki Enomoto, Yutaro Nakamura, Shigeki Kuroishi, Hisano Ohba, Koshi Yokomura, Jun Sato, Masaki Sato, Naoki Koshimizu, Mikio Toyoshima, Takashi Yamada, Masafumi Masuda, Toshihiro Shirai & Takafumi Suda. (2018) Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 12, pages 117954841877170.
Crossref
Crossref
Satoko Ohfuji, Kenji Okada, Takashi Nakano, Hiroaki Ito, Megumi Hara, Haruo Kuroki & Yoshio Hirota. (2017) Control selection and confounding factors: A lesson from a Japanese case-control study to examine acellular pertussis vaccine effectiveness. Vaccine 35:36, pages 4801-4805.
Crossref
Crossref
Nicolas Roche, Kenneth R. Chapman, Claus F. Vogelmeier, Felix J. F. Herth, Chau Thach, Robert Fogel, Petter Olsson, Francesco Patalano, Donald Banerji & Jadwiga A. Wedzicha. (2017) Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial. American Journal of Respiratory and Critical Care Medicine 195:9, pages 1189-1197.
Crossref
Crossref
G. Jébrak, P.-R. Burgel, D. Caillaud, G. Deslée, G. Brinchault, P. Chanez, I. Court-Fortune, R. Escamilla, P. Nesme-Meyer, C. Pinet, T. Perez, J.-L. Paillasseur & N. Roche. (2017) Évolution des traitements de fond entre 2001 et 2012 chez les patients atteints de BPCO en France. Impact de la mise à disposition des anticholinergiques de longue durée d’action. Revue des Maladies Respiratoires 34:5, pages 535-543.
Crossref
Crossref
S. N. Avdeev. (2016) PREVENTION OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. PULMONOLOGIYA 26:5, pages 591-603.
Crossref
Crossref
T. Chinet, J. Dumoulin, I. Honore, J.-M. Braun, L.-J. Couderc, M. Febvre, G. Mangiapan, C. Maurer, P. Serrier, F. Soyez, P. Terrioux & G. Jebrak. (2016) Place des corticostéroïdes inhalés dans la BPCO. Revue des Maladies Respiratoires 33:10, pages 877-891.
Crossref
Crossref
Kazuhisa Asai, Kazuto Hirata, Shu Hashimoto, Yoshinosuke Fukuchi, Tetsuji Kitawaki, Kimitoshi Ikeda, Robert Fogel & Donald Banerji. (2016) Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: Pooled analysis of SHINE and ARISE. Respiratory Investigation 54:6, pages 428-435.
Crossref
Crossref
S. N. Avdeev, Z. R. Aisanov, A. S. Belevskiy, K. A. Zykov, I. V. Leshchenko, S. I. Ovcharenko, E. I. Shmelev, V. V. Arkhipov, Yu. Yu. Gorblyanskiy, A. V. Emel'yanov, G. L. Ignatova, V. A. Kazantsev, N. A. Karoli, S. V. Kolbasnikov, L. M. Kudelya, N. A. Kuzubova, A. I. Sinopal'nikov, I. E. Stepanyan, I. N. Trofimenko, R. S. Fassakhov, R. F. Khamitov & N. L. Shaporova. (2016) A role of long-acting bronchodilator tiotropium / olodaterol fixed combination as the first-line therapy of chronic obstructive pulmonary disease. A Consensus of Expert Board of Russian Respiratory Society. PULMONOLOGIYA 26:4, pages 505-513.
Crossref
Crossref
Barbara P Yawn, Samy Suissa & Andrea Rossi. (2016) Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
E. N. Barabanova & Y. M. Kolontareva. (2016) Inhaled steroids / long6acting β2-agonists in treatment of chronic obstructive pulmonary disease: the discussion goes on. PULMONOLOGIYA 26:3, pages 357-363.
Crossref
Crossref
Alexander I. Sinopal’nikov, I. V. Leshenko & K. Kostikas. (2016) The possibilities and limits of modern bronchodilating therapy for COPD. Clinical Medicine (Russian Journal) 94:6, pages 418-427.
Crossref
Crossref
A.J. Ferreira, A. Reis, N. Marçal, P. Pinto & C. Bárbara. (2016) COPD: A stepwise or a hit hard approach?. Revista Portuguesa de Pneumologia (English Edition) 22:4, pages 214-221.
Crossref
Crossref
Hernan Iannella, Carlos Luna & Grant Waterer. (2016) Inhaled corticosteroids and the increased risk of pneumonia: what’s new? A 2015 updated review. Therapeutic Advances in Respiratory Disease 10:3, pages 235-255.
Crossref
Crossref
Stephanie A. Sutter & Emily M. Stein. (2016) The Skeletal Effects of Inhaled Glucocorticoids. Current Osteoporosis Reports 14:3, pages 106-113.
Crossref
Crossref
S. N. Avdeev, Z. R. Aysanov, A. S. Belevskiy, A. A. Vizel'G. L. Ignatova, N. P. Knyazheskaya, I. V. Leshchenko, S. I. Ovcharenko, V. I. TrofimovE. I. Shmelev. (2016) Perspectives of pharmacological therapy of chronic obstructive pulmonary disease: opportunities of dual bronchodilation and a role of inhaled steroids. Expert Council Consensus. PULMONOLOGIYA 26:1, pages 65-72.
Crossref
Crossref
Salvatore Battaglia, Irene Cardillo, Federico Lavorini, Mario Spatafora & Nicola Scichilone. (2015) Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly. Drugs & Aging 32:12, pages 1067-1076.
Crossref
Crossref
Ming-Chia Lee, Chih-Hsin Lee, Shu-Chen Chien, Jer-Hwa Chang, Han-Lin She, Jann-Yuan Wang & Ming-Chih Yu. (2015) Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease. Medicine 94:42, pages e1723.
Crossref
Crossref
Valerie R. Stolberg, Alexandra L. McCubbrey, Christine M. Freeman, Jeanette P. Brown, Sean W. Crudgington, Sophina H. Taitano, Bridget L. Saxton, Peter Mancuso & Jeffrey L. Curtis. (2015) Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function. The Journal of Immunology 195:1, pages 174-184.
Crossref
Crossref
A. Rouze & S. Nseir. (2015) Pneumonie acquise sous ventilation mécanique chez le patient BPCO : épidémiologie, physiopathologie, préventionVentilator-associated pneumonia in COPD patients: Epidemiology, pathogenesis, prevention. Réanimation 24:3, pages 295-302.
Crossref
Crossref
Satoko Ohfuji, Kenji Okada, Takashi Nakano, Hiroaki Ito, Megumi Hara, Haruo Kuroki & Yoshio Hirota. (2015) Effectiveness of acellular pertussis vaccine in a routine immunization program: A multicenter, case-control study in Japan. Vaccine 33:8, pages 1027-1032.
Crossref
Crossref
Andrea Rossi, Massimo Guerriero & Antonio Corrado. (2014) Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO). Respiratory Research 15:1.
Crossref
Crossref
Lydia Finney, Matthew Berry, Aran Singanayagam, Sarah L Elkin, Sebastian L Johnston & Patrick Mallia. (2014) Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease. The Lancet Respiratory Medicine 2:11, pages 919-932.
Crossref
Crossref
Salvatore Battaglia, Irene Cardillo, Federico Lavorini, Mario Spatafora & Nicola Scichilone. (2014) Safety Considerations of Inhaled Corticosteroids in the Elderly. Drugs & Aging 31:11, pages 787-796.
Crossref
Crossref
Anahita Rouzé, Aurélie Cottereau & Saad Nseir. (2014) Chronic obstructive pulmonary disease and the risk for ventilator-associated pneumonia. Current Opinion in Critical Care 20:5, pages 525-531.
Crossref
Crossref
Daan A. De Coster & Melvyn Jones. (2014) Tailoring of corticosteroids in COPD management. Current Respiratory Care Reports 3:3, pages 121-132.
Crossref
Crossref
Donald Banerji, Robert Fogel & Kai-Michael Beeh. (2014) Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data. Clinical Investigation 4:6, pages 511-533.
Crossref
Crossref
Rachael L. DiSantostefano, Tim Sampson, Hoa Van Le, David Hinds, Kourtney J. Davis & Nawar Diar Bakerly. (2014) Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study. PLoS ONE 9:5, pages e97149.
Crossref
Crossref
Katharine H. Abbott-Banner & Clive P. Page. (2014) Dual PDE3/4 and PDE4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases. Basic & Clinical Pharmacology & Toxicology 114:5, pages 365-376.
Crossref
Crossref
Paola Faverio, Stefano Aliberti, Giuseppe Bellelli, Giulia Suigo, Sara Lonni, Alberto Pesci & Marcos I. Restrepo. (2014) The management of community-acquired pneumonia in the elderly. European Journal of Internal Medicine 25:4, pages 312-319.
Crossref
Crossref
Kayleigh M Kew & Alieksei Seniukovich. (2014) Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2014:12.
Crossref
Crossref
G. Deslée, F. Lebargy & S. Dury. (2013) Quelques brèves d’actualités. Revue des Maladies Respiratoires Actualités 5:6, pages 630-631.
Crossref
Crossref